Catheter ablation for atrial fibrillation: A promising therapy for congestive heart failure

Dimpi Patel; Andrea Natale; Luigi Di Biase; J. David Burkhardt; Yan Wang; Javier E. Sanchez; Rodney P. Horton; Mohammed Khan

doi:10.1586/erc.09.61

Catheter ablation for atrial fibrillation: A promising therapy for congestive heart failure

Dimpi Patel, Andrea Natale, Luigi Di Biase, J. David Burkhardt, Yan Wang, Javier E. Sanchez, Rodney P. Horton, Mohammed Khan

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Atrial fibrillation (AF) and congestive heart failure (CHF) are cardiovascular epidemics. Catheter ablation of AF is increasingly performed in patients with CHF. Atrioventricular junction ablation (AVJA) and pulmonary vein isolation are the two predominant ablation strategies used to treat AF patients who are refractory to drugs. In patients with CHF refractory to drugs, AVJA with a biventricular device is associated with improvement in exercise capacity and quality of life. However, in a head-to-head comparison, pulmonary vein antrum ablation was shown to be superior to AVJA. Cure of AF in patients with CHF resulted in more significant morphological and functional improvements than AVJA.

Original language	English (US)
Pages (from-to)	779-787
Number of pages	9
Journal	Expert Review of Cardiovascular Therapy
Volume	7
Issue number	7
DOIs	https://doi.org/10.1586/erc.09.61
State	Published - Jul 2009
Externally published	Yes

Keywords

Atrial fibrillation
Catheter ablation
Congestive heart failure
Left ventricular systolic dysfunction
Pulmonary vein antral isolation

ASJC Scopus subject areas

Internal Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1586/erc.09.61

Cite this

@article{726693fb53da44a2968733894815b4d5,

title = "Catheter ablation for atrial fibrillation: A promising therapy for congestive heart failure",

abstract = "Atrial fibrillation (AF) and congestive heart failure (CHF) are cardiovascular epidemics. Catheter ablation of AF is increasingly performed in patients with CHF. Atrioventricular junction ablation (AVJA) and pulmonary vein isolation are the two predominant ablation strategies used to treat AF patients who are refractory to drugs. In patients with CHF refractory to drugs, AVJA with a biventricular device is associated with improvement in exercise capacity and quality of life. However, in a head-to-head comparison, pulmonary vein antrum ablation was shown to be superior to AVJA. Cure of AF in patients with CHF resulted in more significant morphological and functional improvements than AVJA.",

keywords = "Atrial fibrillation, Catheter ablation, Congestive heart failure, Left ventricular systolic dysfunction, Pulmonary vein antral isolation",

author = "Dimpi Patel and Andrea Natale and {Di Biase}, Luigi and Burkhardt, {J. David} and Yan Wang and Sanchez, {Javier E.} and Horton, {Rodney P.} and Mohammed Khan",

note = "Funding Information: Andrea Natale is Speaker for St Jude Medical, Boston Scientific, Medtronic and Biosense Webster and Member Advisory Board for Stereotaxis and Biosense Webster. Research grant from St Jude Medical. J David Burkhardt is Speaker for St Jude Medical, Biosense Webster and Chief Medical Officer for Stereotaxis. Rodney Hortonis a member of the Speakers Bureau: Hansen Medical, St. Jude, Medtronic, Boston Scientific, Biosense webster. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",

year = "2009",

month = jul,

doi = "10.1586/erc.09.61",

language = "English (US)",

volume = "7",

pages = "779--787",

journal = "Expert Review of Cardiovascular Therapy",

issn = "1477-9072",

publisher = "Expert Reviews Ltd.",

number = "7",

}

TY - JOUR

T1 - Catheter ablation for atrial fibrillation

T2 - A promising therapy for congestive heart failure

AU - Patel, Dimpi

AU - Natale, Andrea

AU - Di Biase, Luigi

AU - Burkhardt, J. David

AU - Wang, Yan

AU - Sanchez, Javier E.

AU - Horton, Rodney P.

AU - Khan, Mohammed

N1 - Funding Information: Andrea Natale is Speaker for St Jude Medical, Boston Scientific, Medtronic and Biosense Webster and Member Advisory Board for Stereotaxis and Biosense Webster. Research grant from St Jude Medical. J David Burkhardt is Speaker for St Jude Medical, Biosense Webster and Chief Medical Officer for Stereotaxis. Rodney Hortonis a member of the Speakers Bureau: Hansen Medical, St. Jude, Medtronic, Boston Scientific, Biosense webster. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

PY - 2009/7

Y1 - 2009/7

N2 - Atrial fibrillation (AF) and congestive heart failure (CHF) are cardiovascular epidemics. Catheter ablation of AF is increasingly performed in patients with CHF. Atrioventricular junction ablation (AVJA) and pulmonary vein isolation are the two predominant ablation strategies used to treat AF patients who are refractory to drugs. In patients with CHF refractory to drugs, AVJA with a biventricular device is associated with improvement in exercise capacity and quality of life. However, in a head-to-head comparison, pulmonary vein antrum ablation was shown to be superior to AVJA. Cure of AF in patients with CHF resulted in more significant morphological and functional improvements than AVJA.

AB - Atrial fibrillation (AF) and congestive heart failure (CHF) are cardiovascular epidemics. Catheter ablation of AF is increasingly performed in patients with CHF. Atrioventricular junction ablation (AVJA) and pulmonary vein isolation are the two predominant ablation strategies used to treat AF patients who are refractory to drugs. In patients with CHF refractory to drugs, AVJA with a biventricular device is associated with improvement in exercise capacity and quality of life. However, in a head-to-head comparison, pulmonary vein antrum ablation was shown to be superior to AVJA. Cure of AF in patients with CHF resulted in more significant morphological and functional improvements than AVJA.

KW - Atrial fibrillation

KW - Catheter ablation

KW - Congestive heart failure

KW - Left ventricular systolic dysfunction

KW - Pulmonary vein antral isolation

UR - http://www.scopus.com/inward/record.url?scp=70349322416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349322416&partnerID=8YFLogxK

U2 - 10.1586/erc.09.61

DO - 10.1586/erc.09.61

M3 - Review article

C2 - 19589114

AN - SCOPUS:70349322416

SN - 1477-9072

VL - 7

SP - 779

EP - 787

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

IS - 7

ER -

Catheter ablation for atrial fibrillation: A promising therapy for congestive heart failure

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this